Your browser doesn't support javascript.
loading
Arsenic modifies the effect of folic acid in spina bifida prevention, a large hospital-based case-control study in Bangladesh.
Wei, Chih-Fu; Mukherjee, Sudipta Kumar; Ekramullah, Sheikh Muhammad; Arman, D M; Islam, Md Joynul; Azim, Mubinul; Rahman, Asifur; Rahman, Md Nafaur; Ziauddin, Md; Tindula, Gwen; Suchanda, Hafiza Sultana; Gomberg, Diana F; Weisskopf, Marc G; Liang, Liming; Warf, Benjamin C; Christiani, David C; Mazumdar, Maitreyi.
Afiliação
  • Wei CF; Harvard T.H. Chan School of Public Health.
  • Mukherjee SK; National Institute of Neurosciences & Hospital.
  • Ekramullah SM; National Institute of Neurosciences & Hospital.
  • Arman DM; National Institute of Neurosciences & Hospital.
  • Islam MJ; National Institute of Neurosciences & Hospital.
  • Azim M; Dhaka Shishu Hospital.
  • Rahman A; Bangabandhu Sheikh Mujib Medical University (BSMMU).
  • Rahman MN; National Institute of Neurosciences & Hospital.
  • Ziauddin M; National Institute of Neurosciences & Hospital.
  • Tindula G; Stanford University.
  • Suchanda HS; National Institute of Neurosciences & Hospital.
  • Gomberg DF; Boston Children's Hospital.
  • Weisskopf MG; Harvard T.H. Chan School of Public Health.
  • Liang L; Harvard T.H. Chan School of Public Health.
  • Warf BC; Boston Children's Hospital.
  • Christiani DC; Harvard T.H. Chan School of Public Health.
  • Mazumdar M; Harvard T.H. Chan School of Public Health.
Res Sq ; 2024 Feb 29.
Article em En | MEDLINE | ID: mdl-38464105
ABSTRACT

Background:

Spina bifida, a developmental malformation of the spinal cord, is associated with high rates of mortality and disability. Although folic acid-based preventive strategies have been successful in reducing rates of spina bifida, some areas continue to be at higher risk because of chemical exposures. Bangladesh has high arsenic exposures through contaminated drinking water and high rates of spina bifida.

Methods:

We conducted a hospital-based case-control study at the National Institute of Neurosciences & Hospital (NINS&H) in Dhaka, Bangladesh, between December 2016 and December 2022. Cases were infants under age one year with spina bifida and further classified using data from observations by neurosurgeons and available imaging. Controls were drawn from children who presented to NINS&H or Dhaka Shishu Hospital (DSH) during the same study period. Mothers reported folic acid use during pregnancy, and we assessed folate status with serum assays. Arsenic exposure was estimated in drinking water using graphite furnace atomic absorption spectrophotometry (GF-AAS) and in toenails using inductively coupled plasma mass spectrometry (ICP-MS).

Results:

We evaluated data from 294 cases of spina bifida and 163 controls. We did not find a main effect of mother's arsenic exposure on spina bifida risk. However, in stratified analyses, folic acid use was associated with lower odds of spina bifida (adjusted odds ratio [OR] 0.50, 95% confidence interval [CI] 0.25-1.00, p = 0.05) among women with toenail arsenic concentrations below the median, and no association was seen among mothers with toenail arsenic concentrations higher than median (adjusted OR 1.09, 95% CI 0.52-2.29, p = 0.82).

Conclusions:

Mother's arsenic exposure modified the protective association of folic acid with spina bifida. Increased surveillance and additional preventive strategies, such as folic acid fortification and reduction of arsenic, are needed in areas of high arsenic exposure.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos